Complications of Systemic Retinoid Therapy in Organ Transplant Recipients with Squamous Cell Carcinoma

Dermatologic Surgery

Volumn 30, Issue 4 II, 2004, Pages 662-666

  Martinez, Juan Carlos ^a   Otley, Clark C ^b   Euvrard, Sylvie ^c   Arpey, Christopher J ^d   Stasko, Thomas ^e  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITY OF IOWA   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DERMATOLOGICAL AGENT; ETRETIN; ETRETINATE; ISOTRETINOIN; RETINOID;

ACUTE GRAFT REJECTION; ARTHRALGIA; ARTICLE; CHEILITIS; CHILL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRY EYE; FATIGUE; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HUMAN; HYPERTRIGLYCERIDEMIA; LIVER LEVEL; LIVER TOXICITY; MAJOR CLINICAL STUDY; MENTAL INSTABILITY; MUCOSA; NAIL DISEASE; ORGAN TRANSPLANTATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RECIPIENT; SKIN CARCINOMA; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; SYSTEMIC THERAPY; WOUND HEALING IMPAIRMENT; XEROSIS;

EID: 1942508228     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30153.x     Document Type: Article

References (15)

1. Penn I. Immunosuppression and skin cancer. Clin Plast Surg 1980;7:361-8.
2. Barrett WL, First MR, Aron BS, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993;72:2186-9.
3. Glover MT, Niranjan N, Kwan JT, Leigh IM. Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management. Br J Plast Surg 1994;47:86-9.
4. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995;27:1767-8.
5. DiGiovanna JJ. Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol 1998;39:S82-5.
6. DiGiovanna JJ. Posttransplantation skin cancer: scope of the problem, management, and role for systemic retinoid chemoprevention. Transplant Proc 1998;30:2771-5.
7. Bouwes Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995;13:1933-8.
8. Rook AH, Jaworsky C, Nguyen T, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995;59:714-9.
9. Shuttleworth D, Marks R, Griffin PJ, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988;68:717-25.
10. Martinez JC, Otley CC, Stasko T, et al. for the Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003;139-301-6.
11. Gibson GE, O'Grady A, Kay EW, Murphy GM. Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients. J Eur Acad Dermatol Venereol 1998;10:42-7.
12. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999;140:656-60.
13. DiGiovanna JJ. Systemic retinoid therapy. Dermatol Clin 2001;19:161-7.
14. Fulton RA, Souteyrand P, Thivolet J. Influence of retinoid Ro 10-9359 on cell-mediated immunity in vivo. Dermatologica 1982;165:568-72.
15. McKerrow KJ, MacKie RM, Lesko MJ, Pearson C. The effect of oral retinoid therapy on the normal human immune system. Br J Dermatol 1988;119:313-20.